Se prevé que el mercado de agentes de embolización alcance los 4.525,75 millones de dólares en 2028 desde los 2.714,82 millones de dólares en 2021; se espera que crezca a una tasa compuesta anual del 7,6% de 2021 a 2028.
El crecimiento del mercado se atribuye a la creciente incidencia de tumores y aneurismas y a la creciente prevalencia de hipertensión, obesidad, tabaquismo y alcoholismo. Sin embargo, los altos costos de los agentes de embolización frenan el crecimiento del mercado de agentes de embolización. Los agentes de embolización se utilizan para aplicar oclusión mecánica para detener el flujo de sangre en un vaso sanguíneo o área vascular. En radiología intervencionista, la embolización es un procedimiento común. Los procedimientos de embolización se utilizan principalmente para tratar lesiones traumáticas. Los agentes embólicos se presentan en diversas formas, cada una con su propio conjunto de propiedades y aplicaciones. Dependiendo de la duración requerida para la oclusión arterial, los agentes de embolización se clasifican en temporales o permanentes.Perspectivas estratégicas
En los EE. UU., la demanda de procedimientos de tratamiento de las verrugas se ha reducido debido al cambio en la centrarse en el tratamiento de COVID-19. La pandemia de COVID-19 ha causado estragos en las cadenas de suministro, los mercados de consumo y las economías mundiales. Esta situación ha provocado una disminución de los procedimientos cardíacos realizados en varios países de Asia Pacífico. Las medidas implementadas por los gobiernos de todo el mundo han impactado negativamente el crecimiento del mercado de agentes de embolización.
regiones lucrativas para el mercado de agentes de embolización
Perspectivas del mercado
La creciente incidencia de tumores y aneurismas impulsa el crecimiento del mercado de agentes de embolización
Según el Instituto Nacional del Cáncer, en 2020, hubo 1.806.590 nuevos casos de cáncer y 606.520 muertes debido a la enfermedad en EE.UU. En 2020, los cánceres de próstata, pulmón y colorrectal representaron el 43 % de todos los cánceres diagnosticados en hombres. Los cánceres de mama, pulmón y colorrectal son los tres cánceres más frecuentes diagnosticados en las mujeres. Según el informe Estadísticas y hechos de la Brain Aneurysm Foundation, en los EE. UU., alrededor de 6,5 millones de personas, es decir, 1 de cada 50 personas, tienen un aneurisma cerebral no roto. También se ha mencionado que el 20% del total de personas diagnosticadas con un aneurisma cerebral tienen más de un aneurisma. Además, ha informado que, cada año, alrededor de 30.000 personas en los EE. UU. sufren la rotura de un aneurisma cerebral y que se produce una rotura de aneurisma cerebral cada 18 minutos. Además, según el NHS, cada año en el Reino Unido, 1 de cada 12.500 personas sufre la rotura de un aneurisma cerebral en Inglaterra. Además, según el documento ‘Patogénesis de aneurismas intracraneales no rotos y tratamiento individualizado’ Según un informe publicado en Deutsches Ärzteblatt International en 2020, alrededor de 2 millones de personas (adultos) en Alemania tienen un aneurisma intracraneal (IA) no roto. Los agentes de embolización se utilizan para detener de forma aguda el flujo en un vaso sanguíneo o territorio vascular mediante oclusión mecánica. Los agentes embolizantes, como las microesferas embólicas (perlas), se utilizan para restringir el suministro vascular a los tumores y pueden cargarse con medicamentos quimioterapéuticos, que eluyen y difunden en el tejido. Los agentes embólicos líquidos se utilizan para impedir el suministro de sangre a un aneurisma o tumor. Por lo tanto, la creciente prevalencia de aneurismas y cánceres está creando una gran demanda de agentes de embolización.
Información basada en el producto
Según el producto, el mercado de agentes de embolización se segmenta en espirales, perlas/partículas, tapones, globos desmontables, pegamento, esponja, embólicos líquidos, esclerosantes, agentes precipitantes y otros. El segmento de perlas/partículas tiene la mayor cuota de mercado. Sin embargo, se prevé que el segmento de bobinas registre la CAGR más alta durante 2021-2028. La embolización con espiral es un procedimiento basado en catéter que permite la oclusión precisa del flujo sanguíneo anormal en un vaso sanguíneo. El creciente número de cirugías cardíacas está impulsando el crecimiento del mercado de este segmento.Mercado de agentes de embolización, por producto: 2021 y 2028
Información basada en aplicaciones
Según la aplicación, el mercado de agentes de embolización se segmenta en neurología, oncología, cardiología, enfermedades vasculares periféricas, y otras. El segmento de oncología tiene la mayor participación del mercado y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.Información basada en el usuario final
Basado en el usuario final, los agentes de embolización El mercado está segmentado en hospitales, centros quirúrgicos ambulatorios, centros cardíacos y otros. El segmento de hospitales tiene la mayor cuota de mercado y se estima que registrará la CAGR más alta durante el período previsto. El crecimiento del mercado para este segmento se atribuye al creciente número de hospitales en todo el mundo y al rápido crecimiento del número de procedimientos quirúrgicos.Las empresas que operan en el mercado de agentes de embolización están adoptando la estrategia de innovación de productos para satisfacer la evolución demandas de los clientes en todo el mundo, lo que también les permite mantener su marca en el mercado global.
Mercado de agentes de embolización: por producto
- Bobinas
- Bobinas desmontables
- Bobinas empujables
- Cuentas/Partículas
- Esféricos
- No esféricos
- Tapones
- Globos Desmontables
- Pegamento
- Esponja
- Embólicos líquidos
- Esclerosantes
- Agentes precipitantes
- Otros
Mercado de agentes de embolización: por aplicación
- Oncología
- Neurología
- Urología
- Cardiología
- Enfermedades vasculares periféricas
- Otros
Mercado de agentes de embolización: ndash; por usuario final
- Hospitales
- Centros cardíacos
- Centros de cirugía ambulatoria
- Otros
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Oriente Medio y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- América del Sur y Central (SCAM )
- Brasil
- Argentina
- Resto de ESTAFA
Perfiles de Empresas
- Medtronic
- Terumo Corporation
- Cook Medical LLC
- Boston Scientific Corporation
- Abbott < li>Stryker Corporation
- Penumbra, Inc.
- Merit Medical Systems Inc.
- DePuy Synthes
- KANEKA CORPORATION < /ul>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.
The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.
Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.
The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.
Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.
The List of Companies - Embolization Agents Market
- Medtronic
- Terumo Corporation
- Cook Medical LLC
- Boston Scientific Corporation
- Abbott
- Stryker Corporation
- Penumbra, Inc.
- Merit Medical Systems Inc.
- DePuy Synthes
- KANEKA CORPORATION
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)